Evotec SE, a drug discovery and development company, was counseled by Freshfields Bruckhaus Deringer in a debt offering valued at 250 million euros ($278 million). The Freshfields Bruckhaus team included partners Mario Huether and Michael Josenhans.
Banking & Financial Services
August 28, 2024, 10:45 AM